Reuters logo
10 个月前
BRIEF-Dimension Therapeutics announces orphan drug designation of DTX401
2016年10月4日 / 中午12点12分 / 10 个月前

BRIEF-Dimension Therapeutics announces orphan drug designation of DTX401

Oct 4 (Reuters) - Dimension Therapeutics Inc

* Dimension Therapeutics announces orphan drug designation of DTX401 for the treatment of glycogen storage disease type IA (GSDIA) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below